Company: CSLMF
Filing Date: 2025-07-03
Form Type: DEFM14A
Source: 0001193125-25-155514
Chunk: 416

Company: CSLM ACQUISITION CORP.
Filing Date: 2025-07-03
Form: DEFM14A
Chunk 416
---
--|
| Net cash provided by (used in):         |     |               |      |   |     |      |        |   |
| Operating activities                    |     | $             | (229 | ) |     | $    | (1,463 | ) |
| Investing activities                    |     |               |  (24 | ) |     |      |    (55 | ) |
| Financing activities                    |     |               |  180 |   |     |      |  1,458 |   |
| Effect of exchange rate changes on cash |     |               |    2 |   |     |      |      — |   |
| Net increase (decrease) in cash         |     | $             |  (71 | ) |     | $    |    (60 | ) |

Operating Activities Net cash used in operating activities during the quarter ended March 31, 2025, decreased by $1.23 million, to $0.23 million from $1.46 million in the same period 2024. The decrease in operating cashflow is largely on account of decrease in net loss to $0.25 million for the quarter ended March 31, 2025 from $3.3 million for the quarter ended March 31, 2024, due to the change in fair value of convertible notes, decrease in selling and marketing expense on account of stock-based compensation due to the completion of vesting for previously granted awards and increase in working capital changes to $0.92 million from $ (0.05) million. The $0.23 million net cash used in operating activities in 2025 was primarily related to (i) a net loss of $0.25 million, offset by; (ii) depreciation and amortization of $0.05 million; (iii) provision for credit losses of $0.08 million; (iv) stock-based compensation of $0.07 million; (v) amortization of right-of-useassets of $0.02 million; (vi) loss on extinguishment of debt of $0.4 million; (vii) changes in fair value of Convertible Notes at Fair Value of $1.54 million; (viii) change in fair value of common stock warrant liability of $0.03 million. Accretion of cumulative mandatorily redeemable common and preferred stock liability of $0.02 million; (ix) Working capital changes of $0.92 million. Net cash used